Market Cap 26.39M
Revenue (ttm) 0.00
Net Income (ttm) -26.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 211,800
Avg Vol 203,346
Day's Range N/A - N/A
Shares Out 7.25M
Stochastic %K 62%
Beta 1.26
Analysts Strong Buy
Price Target $40.00

Company Profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agree...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 921 1810
Fax: 604 921 1898
Address:
Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada
typevoid
typevoid Jun. 3 at 11:13 AM
$BCTX 8-K: Raised $4.71M by selling 1.45M shares at $3.25. Provides immediate liquidity but results in equity dilution. Warrants issued to agent at $4.0625. check out the filing: http://s.founcha.com/OmSY6
1 · Reply
EscapePlan
EscapePlan Jun. 3 at 1:45 AM
$BCTX I’m struggling with greed etc here… all the signs are great. I have 30,000 warrants (bctxl) and it’s sooooooo tempting keep loading up. Feels like it could easily get to $10 plus on good readout later this year. The recent raise gives extra runway, and if there was any whiff of buy out or partnership this could surely hit $20+. Very tempting to go in more on the basis that a 10-20x return on the warrants are just too good to pass on. I’d welcome input on your price targets folks. Are you looking at $10-20 or do you feel that longer haul this could go higher. Part of me is saying fuck it, take it up to 50,000. If it doesn’t work out it’s painful, but if it does then you’re taking home over a million in the next couple of years…. Greedy, but doesn’t seem too much of a stretch to me….
1 · Reply
MoeMaze
MoeMaze Jun. 2 at 11:56 PM
$BCTX someone bought 1M shares for 3250000 , knowing for sure in a couple of weeks maybe months it will b with one extra 0 if Not 2 Zeros $00 , so guys be happy from today u want c it red and if it does it won’t be anything to be mentioned more of a camouflage 😉
0 · Reply
TWBXX
TWBXX Jun. 2 at 9:16 PM
$BCTX PHILADELPHIA & VANCOUVER, British Columbia, June 02, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today announced the closing of its best-efforts offering of 1,449,300 common shares. Each common share was sold at an offering price of $3.25 per share.
2 · Reply
frontiere
frontiere Jun. 2 at 8:12 PM
$BCTX BriaCell ref=$3.25 — Long small size — have traded successfully before, trading sardine approach, not buy and hold. 👍 Offering closed nicely, no wrts, bullish.
0 · Reply
Manwiththeplan
Manwiththeplan Jun. 2 at 6:53 PM
$BCTX i am.reading about briacell. I am pretty positive here. Why is market cap this low? Looks like phase 3 is going in the right direction.
1 · Reply
ZacksResearch
ZacksResearch Jun. 2 at 5:53 PM
$BCTX Phase 3 breast cancer data turning heads at ASCO 👀 BriaCell reported encouraging Phase 2 and ongoing Phase 3 findings in heavily pretreated metastatic breast cancer patients: 📈 Median overall survival reached 16.6 months with the Phase 3 regimen 🎯 More than 55% survived 1 year and more than 27% survived 2 years ✅ No treatment-related discontinuations and no unexpected safety signals 💪 Phase 3 data also showed preserved quality of life and meaningful time without symptoms or significant toxicity See what Wall Street expects next 👉 https://www.zacks.com/stock/research/BCTX/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-38279&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_38279
0 · Reply
MoeMaze
MoeMaze Jun. 2 at 3:03 PM
$BCTX something is fishy this time , why didn’t the price go DOWN ! Who do you think is BUYING !
1 · Reply
Merlintrader
Merlintrader Jun. 2 at 6:39 AM
$IMTX ASCO 2026 Oncology Signals, Part Two: $IMTX, $ACTU and $BCTX Highlight Three Higher-Risk Cancer Stories Beyond the Headline Data https://www.merlintrader.com/asco-2026-oncology-signals-part2-imtx-actu-bctx/
0 · Reply
Stonehands
Stonehands Jun. 1 at 6:44 PM
$BCTX I bought back in today
2 · Reply
Latest News on BCTX
BriaCell Therapeutics Announces Closing of Offering

Tue, 02 Jun 2026 16:05:00 -0400 - 17 hours ago

BriaCell Therapeutics Announces Closing of Offering


BriaCell Presents Positive Clinical Data at ASCO 2026

Mon, 01 Jun 2026 07:30:00 -0400 - 2 days ago

BriaCell Presents Positive Clinical Data at ASCO 2026


BriaCell Therapeutics Announces Pricing of Offering

Sun, 31 May 2026 19:59:00 -0400 - 2 days ago

BriaCell Therapeutics Announces Pricing of Offering


BriaCell announces data from Bria-IMT at ASCO 2026

2026-05-22T11:49:02.000Z - 12 days ago

BriaCell announces data from Bria-IMT at ASCO 2026


BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients

Tue, 12 May 2026 07:30:00 -0400 - 22 days ago

BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients


BriaCell receives FDA clearance to initiate Bria-BRES+ trial

2026-05-07T04:03:56.000Z - 27 days ago

BriaCell receives FDA clearance to initiate Bria-BRES+ trial


BriaCell Announces Six Clinical Data Presentations at ASCO 2026

Mon, 27 Apr 2026 07:30:00 -0400 - 5 weeks ago

BriaCell Announces Six Clinical Data Presentations at ASCO 2026


BriaCell presents anti-cancer activity of Bria-OTS

2026-04-21T11:54:23.000Z - 6 weeks ago

BriaCell presents anti-cancer activity of Bria-OTS


BriaCell to present four posters at the 2026 AACR

2026-03-18T11:42:55.000Z - 2 months ago

BriaCell to present four posters at the 2026 AACR


BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

Thu, 05 Mar 2026 16:04:00 -0500 - 3 months ago

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting


BriaCell (BCTX) Reports Promising Phase 2 Survival Data

2026-01-27T13:32:37.000Z - 4 months ago

BriaCell (BCTX) Reports Promising Phase 2 Survival Data


Is the Market Bullish or Bearish on BriaCell Therapeutics Corp?

2026-01-19T16:00:45.000Z - 4 months ago

Is the Market Bullish or Bearish on BriaCell Therapeutics Corp?


BriaCell Therapeutics Announces Closing of US$30 million Public Offering

Thu, 15 Jan 2026 16:05:00 -0500 - 4 months ago

BriaCell Therapeutics Announces Closing of US$30 million Public Offering


What's Going On With BriaCell Therapeutics Stock Wednesday?

2026-01-14T11:36:30.000Z - 5 months ago

What's Going On With BriaCell Therapeutics Stock Wednesday?


BriaCell (BCTX) Unveils $30M Public Offering, Stock Dips 9.7%

2026-01-14T10:55:53.000Z - 5 months ago

BriaCell (BCTX) Unveils $30M Public Offering, Stock Dips 9.7%


BriaCell Therapeutics (BCTX) Launches $30M Public Offering

2026-01-14T06:56:44.000Z - 5 months ago

BriaCell Therapeutics (BCTX) Launches $30M Public Offering


BriaCell Therapeutics trading resumes

2026-01-13T14:41:11.000Z - 5 months ago

BriaCell Therapeutics trading resumes


BriaCell Therapeutics trading halted, volatility trading pause

2026-01-13T14:35:29.000Z - 5 months ago

BriaCell Therapeutics trading halted, volatility trading pause


BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

Oct 20, 2025, 7:30 AM EDT - 8 months ago

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025


BriaCell Announces Proposed Effective Date of Share Consolidation

Aug 21, 2025, 12:00 PM EDT - 10 months ago

BriaCell Announces Proposed Effective Date of Share Consolidation


BriaCell Awarded New Zealand Patent for its Whole Cell Technology

Jul 30, 2025, 7:30 AM EDT - 11 months ago

BriaCell Awarded New Zealand Patent for its Whole Cell Technology


typevoid
typevoid Jun. 3 at 11:13 AM
$BCTX 8-K: Raised $4.71M by selling 1.45M shares at $3.25. Provides immediate liquidity but results in equity dilution. Warrants issued to agent at $4.0625. check out the filing: http://s.founcha.com/OmSY6
1 · Reply
EscapePlan
EscapePlan Jun. 3 at 1:45 AM
$BCTX I’m struggling with greed etc here… all the signs are great. I have 30,000 warrants (bctxl) and it’s sooooooo tempting keep loading up. Feels like it could easily get to $10 plus on good readout later this year. The recent raise gives extra runway, and if there was any whiff of buy out or partnership this could surely hit $20+. Very tempting to go in more on the basis that a 10-20x return on the warrants are just too good to pass on. I’d welcome input on your price targets folks. Are you looking at $10-20 or do you feel that longer haul this could go higher. Part of me is saying fuck it, take it up to 50,000. If it doesn’t work out it’s painful, but if it does then you’re taking home over a million in the next couple of years…. Greedy, but doesn’t seem too much of a stretch to me….
1 · Reply
MoeMaze
MoeMaze Jun. 2 at 11:56 PM
$BCTX someone bought 1M shares for 3250000 , knowing for sure in a couple of weeks maybe months it will b with one extra 0 if Not 2 Zeros $00 , so guys be happy from today u want c it red and if it does it won’t be anything to be mentioned more of a camouflage 😉
0 · Reply
TWBXX
TWBXX Jun. 2 at 9:16 PM
$BCTX PHILADELPHIA & VANCOUVER, British Columbia, June 02, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today announced the closing of its best-efforts offering of 1,449,300 common shares. Each common share was sold at an offering price of $3.25 per share.
2 · Reply
frontiere
frontiere Jun. 2 at 8:12 PM
$BCTX BriaCell ref=$3.25 — Long small size — have traded successfully before, trading sardine approach, not buy and hold. 👍 Offering closed nicely, no wrts, bullish.
0 · Reply
Manwiththeplan
Manwiththeplan Jun. 2 at 6:53 PM
$BCTX i am.reading about briacell. I am pretty positive here. Why is market cap this low? Looks like phase 3 is going in the right direction.
1 · Reply
ZacksResearch
ZacksResearch Jun. 2 at 5:53 PM
$BCTX Phase 3 breast cancer data turning heads at ASCO 👀 BriaCell reported encouraging Phase 2 and ongoing Phase 3 findings in heavily pretreated metastatic breast cancer patients: 📈 Median overall survival reached 16.6 months with the Phase 3 regimen 🎯 More than 55% survived 1 year and more than 27% survived 2 years ✅ No treatment-related discontinuations and no unexpected safety signals 💪 Phase 3 data also showed preserved quality of life and meaningful time without symptoms or significant toxicity See what Wall Street expects next 👉 https://www.zacks.com/stock/research/BCTX/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-38279&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_38279
0 · Reply
MoeMaze
MoeMaze Jun. 2 at 3:03 PM
$BCTX something is fishy this time , why didn’t the price go DOWN ! Who do you think is BUYING !
1 · Reply
Merlintrader
Merlintrader Jun. 2 at 6:39 AM
$IMTX ASCO 2026 Oncology Signals, Part Two: $IMTX, $ACTU and $BCTX Highlight Three Higher-Risk Cancer Stories Beyond the Headline Data https://www.merlintrader.com/asco-2026-oncology-signals-part2-imtx-actu-bctx/
0 · Reply
Stonehands
Stonehands Jun. 1 at 6:44 PM
$BCTX I bought back in today
2 · Reply
Stonehands
Stonehands Jun. 1 at 6:43 PM
$BCTX BriaCell Presents Positive Clinical Data at ASCO 2026 | FirstWord Pharma https://share.google/2oJiJYlVc9YP3qSmB
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 1 at 6:39 PM
All Day Stocks : #ASCO2026 win for $BCTX • Strong surv... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177659616 via @Investors_Hub
0 · Reply
Grinchysimon
Grinchysimon Jun. 1 at 6:38 PM
$BCTX if you go onto @Kirubin account and read his posts. He basically has a selection of different stocks that he repeatedly slates the stocks and insults others in the same manner. He is a shorter. Don’t listen to a word he says and block and report him.
7 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 1 at 6:15 PM
$BCTX showing what investors want - MOMO'S BREAKOUT BOARD https://investorshangout.com/post/view?id=6832049
0 · Reply
ZacksResearch
ZacksResearch Jun. 1 at 6:10 PM
$BCTX just priced a $4.7M offering — what investors need to know ⚠️ BriaCell announced a best-efforts offering of 1,449,300 common shares at $3.25 per share, with expected gross proceeds of approximately $4.7 million. 💰 Net proceeds are intended for working capital, general corporate purposes, and advancing business objectives 📅 The offering is expected to close on June 2, 2026, subject to customary closing conditions See what Wall Street expects next 👉 https://www.zacks.com/stock/research/BCTX/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-38259&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_38259
1 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 1 at 5:26 PM
BB's Stock Haven : $BCTX showing what investors want to see... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177659613 via @Investors_Hub
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 1 at 4:47 PM
$BCTX BriaCell Presents Positive Clinical Data at ASCO 2026 https://www.globenewswire.com/news-release/2026/06/01/3304255/0/en/briacell-presents-positive-clinical-data-at-asco-2026.html @smallcapvoice
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 1 at 4:10 PM
$BCTX Announced positive clinical data from three clinical data poster presentations at the 2026 ASCO Annual Meeting, taking place May 29-June 2, 2026 at McCormick Place, Chicago, Illinois. #Biotech #StocksToWatch #Healthcare NEWS: https://bit.ly/3Se0RRi $LLY $JNJ $PFE
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 1 at 3:50 PM
#ASCO2026 win for $BCTX • Strong survival data (Phase 2) • Positive QoL + tolerability signals • Biomarker validation for Phase 3 Translation: Better outcomes and lower toxicity risk That combo drives adoption + valuation. #StocksToWatch NEWS: https://bit.ly/3Se0RRi $LLY
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 1 at 3:07 PM
$BCTX showing what investors want to see: 👉 Durable survival in late-stage cancer 👉 Biomarkers validating response 👉 Early Phase 3 momentum building In a space where options are limited, long-term survivor cohorts matter. #Biotech #ASCO2026 NEWS: https://bit.ly/3Se0RRi
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 1 at 2:47 PM
BriaCell Therapeutics Corp ( $BCTX ): CANCER STOCK NEWS: $BCTX delivers at AS... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177658440 via @Investors_Hub
0 · Reply
JediGreen
JediGreen Jun. 1 at 2:21 PM
$BCTX how much was trodelvy sold for - Google Search https://www.google.com/search?q=how+much+was+trodelvy+sold+for&sca_esv=5f802be1e67c425f&source=hp&ei=CZUdapunCu-mruEPkdrdkAc&biw=430&bih=721&oq=how+much+was+trodelvy&gs_lp=EhFtb2JpbGUtZ3dzLXdpei1ocCIVaG93IG11Y2ggd2FzIHRyb2RlbHZ5KgIIADIFECEYoAEyBRAhGKABMgUQIRigATIFECEYoAEyBhAAGBYYHjIFECEYnwVI29UCUJsMWJjIAnANeACQAQCYAaABoAGtGKoBBTE0LjE1uAEByAEA-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&sclient=mobile-gws-wiz-hp#lfId=ChxjMe
2 · Reply